NDC 68382-655-30 - glyburide and metformin hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68382-655
- Requested NDC
- 68382-655-30
- Package NDCs from labels
- 68382-655-06, 68382-655-16, 68382-655-01, 68382-655-05, 68382-655-10, 68382-655-30, 68382-655-77
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc.
- Effective date
- 2026-06-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| glyburide and metformin hydrochloride - Zydus Pharmaceuticals (USA) Inc. | Zydus Pharmaceuticals (USA) Inc. | 2026-06-10 | HUMAN PRESCRIPTION DRUG LABEL |
| glyburide and metformin hydrochloride - Bryant Ranch Prepack | Bryant Ranch Prepack | 2021-12-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Glyburide and Metformin Hydrochloride Tablets, USP Rx only | Preferred Pharmaceuticals Inc. | 2020-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68382-655-01 | glyburide and metformin hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 6 | |
| 68382-655-05 | glyburide and metformin hydrochloride | 500 in 1 BOTTLE | TABLET | 500 | 6 | |
| 68382-655-06 | glyburide and metformin hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 6 | |
| 68382-655-10 | glyburide and metformin hydrochloride | 1000 in 1 BOTTLE | TABLET | 1000 | 6 | |
| 68382-655-16 | glyburide and metformin hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 6 | |
| 68382-655-30 | glyburide and metformin hydrochloride | 10 in 1 BLISTER PACK | TABLET | 10 | 6 | |
| 68382-655-77 | glyburide and metformin hydrochloride | 10 in 1 CARTON | TABLET | 10 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride Extended-Release 500mg | METFORMIN HYDROCHLORIDE | Calvin Scott & Co., Inc. | e9cd0d23-56eb-40dd-abf4-9e681ec220f5 | 2023-02-07 | Warnings | 786Z46389E |
| GLYBURIDE | GLYBURIDE | A-S Medication Solutions | 3c91a408-973b-4572-832f-515f61d5be1f | 2023-02-04 | Adverse reactions | SX6K58TVWC |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Macleods Pharmaceuticals Limited | 623b3bc6-1b07-4a04-bc7a-7fc695adf063 | 2023-01-18 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Josie Maran Argan Daily Moisturizer SPF47 | ZINC OXIDE, TITANIUM DIOXIDE | Autumn Harp, Inc. | 027821e6-db7d-4c03-956a-00313488ebc7 | 2023-01-14 | Boxed warning, Warnings | 15FIX9V2JP |
| Vitrexyl plus Iron | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ada43056-a3ce-e7de-e053-2a95a90aa046 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Vitrexyl | FOLIC ACID | PureTek Corporation | ae064a9e-daba-fa86-e053-2a95a90a16a7 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Vitranol Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b81daf17-430b-6ba2-e053-2a95a90a768b | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Vitrexate | FOLIC ACID | PureTek Corporation | b34fee43-bea9-45b7-e053-2a95a90aad4d | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Vitrexate FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b3637def-a701-673a-e053-2995a90a02d5 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Venexa | FOLIC ACID | PureTek Corporation | ba130779-cdfd-086d-e053-2a95a90a2590 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Venexa FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ba142128-21c4-4204-e053-2a95a90ae0d7 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Ventrixyl Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | c7a626ec-88ec-d899-e053-2a95a90ab0ba | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | H0G9379FGK |
| Glyburide | GLYBURIDE | Teva Pharmaceuticals USA, Inc. | e84c0dfc-a4e9-4c89-b6ea-45732eb412f5 | 2023-01-09 | Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide | GLYBURIDE | Cadila Pharmaceuticals Limited | ea7a055b-64f0-46bf-aa8e-4a2ef5c3c035 | 2022-12-29 | Warnings, Adverse reactions | SX6K58TVWC |
| Glyburide | GLYBURIDE | Modavar Pharmaceuticals LLC | a5de0ef6-4c8b-40ab-b0ed-2003a8086750 | 2022-12-29 | Warnings, Adverse reactions | SX6K58TVWC |
| EARACHE DROPS | BELLADONNA LEAF, CALCIUM CARBONATE, CHAMOMILE, LYCOPODIUM CLAVATUM SPORE, ANEMONE PATENS, AND SULFUR | Hyland's Inc. | 9b18453e-e338-4b8e-9856-85aca8c46ee1 | 2022-12-12 | Warnings | H0G9379FGK |
| glyburide | GLYBURIDE | Zydus Lifesciences Limited | 5d0e406f-285d-4716-8971-82f665345517 | 2022-11-16 | Adverse reactions | SX6K58TVWC |
| glyburide | GLYBURIDE | Zydus Pharmaceuticals (USA) Inc. | 87781ea8-62ec-483c-a4dd-8c965ce59485 | 2022-11-16 | Adverse reactions | SX6K58TVWC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.